PD27-06 THULIUM LASER VAPORESECTION OF THE PROSTATE AND BIPOLAR TRANSURETHRAL RESECTION OF THE PROSTATE IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA – SINGLE CENTER PROSPECTIVE RANDOMIZED STUDY

Abstract

You have accessJournal of UrologyBenign Prostatic Hyperplasia: Surgical Therapy & New Technology IV1 Apr 2017PD27-06 THULIUM LASER VAPORESECTION OF THE PROSTATE AND BIPOLAR TRANSURETHRAL RESECTION OF THE PROSTATE IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA – SINGLE CENTER PROSPECTIVE RANDOMIZED STUDY Prarthan Joshi, Puvvada Sandeep, Prasad Mylarappa, Ramesh Desigowda, Arvind Nayak, and Kuldeep Aggarwal Prarthan JoshiPrarthan Joshi More articles by this author , Puvvada SandeepPuvvada Sandeep More articles by this author , Prasad MylarappaPrasad Mylarappa More articles by this author , Ramesh DesigowdaRamesh Desigowda More articles by this author , Arvind NayakArvind Nayak More articles by this author , and Kuldeep AggarwalKuldeep Aggarwal More articles by this author View All Author Informationhttps://doi.org/10.1016/j.juro.2017.02.1227AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookTwitterLinked InEmail INTRODUCTION AND OBJECTIVES In recent years, laser surgery has been widely used to treat benign prostatic hyperplasia (BPH). A thulium laser was recently introduced for BPH surgery. We compared the effectiveness and safety of thulium laser vaporesection of the prostate (ThuVaRP) with that of bipolar transurethral resection of the prostate (TURP). METHODS From January 2014 to March 2016, 186 patients who were advised TURP for symptomatic BPH were randomized into two groups. We analyzed and compared outcomes of 93 patients who underwent ThuVaRP and 93 patients who underwent bipolar TURP. All patients were assessed by using the International Prostate Symptom Score, transrectal ultrasonography, the serum prostate-specific antigen (PSA) level, uroflowmetry, and postvoid residual volume before and 1 month after surgery. These patients were followed up for six months. All complications and short term outcomes were compared between the two groups. RESULTS ThuVaRP was superior to TURP in catheterization time and length of hospital stay. However, operation time was longer with ThuVaRP than with TURP. In patients with a large prostate more then 100 grams, operation time was much longer with ThuVaRP. One month after surgery, the decrease in PSA was greater with ThuVaRP than with TURP, and the increase in maximal urine flow rate was greater with ThuVaRP than with TURP. The postoperative complication transient urinary incontinence was significantly different between the ThuVaRP group (17.6%) and the TURP group (4.2%). Other complications and short term followup results were comparable between both groups. CONCLUSIONS The effectiveness and safety of ThuVaRP and TURP were comparable. ThuVaRP is a promising alternative surgical technique to TURP for BPH © 2017FiguresReferencesRelatedDetails Volume 197Issue 4SApril 2017Page: e513 Advertisement Copyright & Permissions© 2017MetricsAuthor Information Prarthan Joshi More articles by this author Puvvada Sandeep More articles by this author Prasad Mylarappa More articles by this author Ramesh Desigowda More articles by this author Arvind Nayak More articles by this author Kuldeep Aggarwal More articles by this author Expand All Advertisement Advertisement PDF downloadLoading ...